Smartphone App Fails FTC Test On Measuring Blood Pressure
This article was originally published in The Pink Sheet
A settlement with "Instant Blood Pressure App" marketer Aura Labs marks FTC's latest enforcement against firms marketing OTC devices that make unsubstantiated health claims.
You may also be interested in...ï»¿
So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go outside its "scope of review" and note unclear instructions on Plavinol labels.